Precigen Inc

PGEN

Company Profile

  • Business description

    Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

  • Contact

    20374 Seneca Meadows Parkway
    GermantownMD20876
    USA

    T: +1 301 556-9900

    E: [email protected]

    http://www.precigen.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    25

Stocks News & Analysis

stocks

10 best global blue-chip stocks to buy for the long term

The stocks of these high-quality companies with large market capitalizations look undervalued today.
stocks

3 overvalued ASX shares going into earnings

Prices of these shares exceed our Fair Value Estimate by more than double.
stocks

The long-term case for compounders

Compounders tend to deliver steadier, more durable profit growth across full cycles, making them better suited for long-term investors.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,068.8042.20-0.46%
CAC 408,126.5355.170.68%
DAX 4024,538.81229.350.94%
Dow JONES (US)48,892.47179.09-0.36%
FTSE 10010,223.5451.780.51%
HKSE26,590.63796.48-2.91%
NASDAQ23,461.82223.30-0.94%
Nikkei 22552,774.50548.35-1.03%
NZX 50 Index13,412.4410.74-0.08%
S&P 5006,939.0329.98-0.43%
S&P/ASX 2008,778.6042.50-0.48%
SSE Composite Index4,046.6771.27-1.73%

Market Movers